Clinical Trials Browser

Solid Tumor × Gefitinib × Other solid neoplasm × Clear all

NCT02447419 2022-06-15

Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumor